01 15Sprycel
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 2,140
2019 Revenue in Millions : 2,110
Growth (%) : 1
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 2,117
2020 Revenue in Millions : 2,140
Growth (%) : -1
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 298
2019 Revenue in Millions : 294
Growth (%) : 1
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 2,165
2021 Revenue in Millions : 2,117
Growth (%) : 2
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 1,930
2022 Revenue in Millions : 2,165
Growth (%) : -11
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions : 16.60%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 1,493
2014 Revenue in Millions : 1,620
Growth (%) : 9%
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 2,005
2016 Revenue in Millions : 1,824
Growth (%) : 10
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 1,824
2015 Revenue in Millions : 1,620
Growth (%) : 13
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 2,000
2017 Revenue in Millions : 2,005
Growth (%) : -0.20%
LOOKING FOR A SUPPLIER?